Campaigners Threaten Legal Action Over UK-US Drug Pricing Deal Impacting NHS
Campaign groups Global Justice Now and Just Treatment are threatening legal action against the UK government over a drug pricing deal with the US. The deal, part of a broader agreement with the Trump administration, allows the UK health secretary to override the National Institute for Health and Care Excellence (Nice) on drug pricing decisions for the NHS. Critics argue this undermines Nice's independence and could lead to higher drug costs. The groups have warned the Department of Health and Social Care (DHSC) they will seek a judicial review unless the statutory instrument enabling this change is revoked. The DHSC maintains that Nice's independence will remain intact, emphasizing the deal's potential to provide NHS patients with access to innovative medicines. 
